Breakthroughs Blog

Breakthroughs brings you stories of bright ideas and bold innovations in global health.

The Latest
Ansley Kahn
Research Roundup: Congo confirms the end of its Ebola outbreak, new treatments for HIV and malaria

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Recent

PATH/Gabe Bienczycki
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Patrick McKern
Research Roundup: What we're reading this week

Welcome to the first Research Roundup post. In this regular feature, we’ll highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Heng Chivoan
Top 10 2011 policy breakthroughs in global health R&D

2011 was a year full of exciting advances in global health research and development, complicated by a volatile budget climate.

GHTC
Read More
Photos show "moving circle" of research breakthroughs

Emily Halnon is the Communications Associate at GHTC. Below is her reaction to a photo reception documenting programs in Kenya that GHTC hosted last week.

GHTC
Read More
PATH/Evelyn Hockstein
GHTC Photo Reception Highlights Research Breakthroughs in Kenya

In countries like Kenya, some of the most incredible global health research is taking place to develop new drugs, vaccines, diagnostics and other health products. In addition, previous research has lead to the roll-out of lifesaving health tools such as HIV/AIDS drugs, vaccines to protect children from pneumonia, and insecticide-treated bednets to prevent malaria.

GHTC
Read More
IPM receives USAID award to advance dual-purpose prevention ring for women

Luann Tia Blount is the Clinical Communications Officer for GHTC member the International Partnership for Microbicides (IPM), a nonprofit product development partnership dedicated to developing new HIV prevention technologies and making them available to women in developing countries. This post discusses novel approaches to HIV prevention, namely an adapted medical technology used to deliver hormones to women—the vaginal ring.

Read More
New report shows a decline in funding for neglected disease R&D

Earlier today, the fourth annual G-FINDER report was released. This resource, developed by Policy Cures, is the only one of its kind that maps the global level of investment in developing new vaccines, drugs, diagnostics, and other tools that address 31 neglected diseases. This year’s report studies funding levels and trends in 2010.

GHTC
Read More
RV144 and the future of an HIV vaccine

Kevin Fisher is the Policy Director for GHTC member AVAC: Global Advocacy for HIV Prevention, an organization that focuses on accelerating the development and delivery of critical AIDS vaccines and HIV treatment and prevention tools. AVAC and partners are hosting a congressional briefing this week to discuss promising results from a Military HIV Research Program’s (MHRP)-sponsored trial to develop a safe and effective HIV vaccine.

AVAC
Read More
‘Make no mistake, we are going to win this fight’

Yesterday, at an event hosted by ONE and (RED) to commemorate World AIDS Day, President Obama declared the beginning of the end of AIDS: “Today is a remarkable day. Today, we come together, as a global community, across continents, faiths and cultures, to renew our commitment to ending the AIDS pandemic –once and for all.”

GHTC
Read More
Building developing country capacity is key in the battle against HIV/AIDS

As we commemorate World AIDS Day 2011, I am both encouraged by the recent discoveries that are improving and prolonging lives and reminded of the challenges that remain in our battle to defeat this terrible disease.

Read More
Leading with science, we can end the AIDS pandemic

December 1 marks the commemoration of World AIDS Day—a day to reflect on an epidemic that has affected millions of lives worldwide for three decades now and how far we’ve come towards an end. This year’s focus and theme is a right on target: “Leading with Science, United for Action.”

Read More
PATH/Patrick McKern
Shifting the bottom line—can R&D tax credits work for diseases of the poor?

Aarthi Rao is a senior program associate at the Center for Global Health R&D Policy Assessment of the Results for Development Institute. This post shares some of the main findings of the Center's recent report, "R&D Tax Credits: A Tool to Advance Global Health Technologies?"

Read More
Major project launched to boost kala-azar elimination in South Asia

A comprehensive four-year project to boost kala-azar elimination strategies in India and Bangladesh, where the concentration of disease burden is among the world's highest, was launched by an international consortium formed last month to support the countries' control and elimination strategies.

OneWorld Health
Read More
PATH/Robin Biellik
GHTC Director highlights progress in developing new interventions for HIV/AIDS

The past three years have been historic in the number of breakthroughs in research to prevent, diagnose, and treat HIV and AIDS.

GHTC
Read More
Better Health, Stronger Economies: Investing in Global Health Research & Development

R!A, in partnership with Aeras, the International AIDS Vaccine Initiative, the International Partnership for Microbicides and OneWorld Health, hosted a Capitol Hill briefing Nov. 15 on the role of product development partnerships (PDPs) in global health R&D.

Research!America
Read More
‘The biggest thing we are leaving behind is intellectual capital’

One of the most overlooked benefits of US-funded global health research is the training provided to scientists to do the work in their own communities.

Read More
A chorus of demands for new TB vaccines

Jamie Rosen is the media & communications manager for Aeras, a GHTC member. Aeras and the TuBerculosis Vaccine Initiative (TBVI) recently hosted a booth at the Union World Conference on Lung Health to hear from conference attendees about the need for a new TB vaccine. This blog post reflects what Aeras heard and experienced at the conference.

Aeras
Read More
PATH/Gabe Bienczycki
The goal of an AIDS-free generation: The time to invest in science is now

Mitchell Warren, the executive director of AVAC and a founding member of GHTC, wrote the following op-ed in reaction to Secretary of State Hillary Clinton’s speech at the National Institutes of Health and her announcement to prioritize achieving an AIDS-free generation. This op-ed originally appeared in The Hill’s “Congress Blog” this week.

AVAC
Read More
New collaboration to Bolster the fight against TB

The most recent WHO TB Control report noted that rates of TB declined this past year for the first time in decades. However, even with such progress, TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease.

TB Alliance
Read More
PATH/Wendy Stone
GHTC members weigh in on importance of HIV/AIDS research

After Secretary of State Hillary Clinton’s speech at the NIH earlier this week, GHTC asked our member organizations involved in HIV/AIDS why the US should continue to prioritize HIV/AIDS research.

GHTC
Read More